We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Tumor Necrosis Factor Displays Anti-Inflammatory Behavior in Rheumatoid Arthritis

By LabMedica International staff writers
Posted on 09 Jun 2011
The proinflammatory protein tumor necrosis factor (TNF) has been found to have an additional, previously unsuspected anti-inflammatory function that might be coopted for treatment of chronic inflammatory conditions such as rheumatoid arthritis.

Investigators at the Hospital for Special Surgery (New York, NY, USA) worked with an in vitro model in which human monocytes and macrophages - cells that have a key role in inflammatory diseases - were treated with TNF and then challenged with LPS (lipopolysaccharide), a potent inflammatory factor that stimulates receptors important in inflammation.

They reported in the May 22, 2011, online edition of the journal Nature Immunology that TNF suppressed the inflammatory response of the macrophages and monocytes. More...
Furthermore, in a set of in vivo experiments they found that mice treated with low doses of TNF were protected from subsequent lethal high doses of LPS. Suppression of the inflammatory response by TNF involved the protein GSK3 (glycogen synthase kinase 3-alpha) as well as the TNFAIP3 gene, which encodes the A20 protein.

"We think it is relevant to rheumatoid arthritis, not only because the cells we are studying (the macrophages) are exactly the same cells that migrate into joints and make the inflammatory cytokines involved in rheumatoid arthritis, but because A20 is involved," said senior author Dr. Lionel Ivashkiv, associate chief scientific officer at the Hospital for Special Surgery. "TNFAIP3 is one of the best linked genes to rheumatoid arthritis. There are polymorphisms in the A20 gene that have been linked to rheumatoid arthritis pathogenesis."

"Prior to this study, TNF has long been known as a potent proinflammatory cytokine, but if you look carefully through the literature, there are hints that it also has some suppressive functions, but nothing was known about the mechanisms," said Dr. Ivashkiv. "This is really the first mechanism showing how TNF can turn inflammation down."

Related Links:
Hospital for Special Surgery



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.